Track 03: HIV Vaccines


An AIDS antibody doesn't yet exist, however endeavors to build up an immunization against HIV, the infection that causes AIDS, have been in progress for a long time. A HIV antibody could be viable in both of two different ways. A "preventive" immunization would stop HIV contamination happening through and through, while a "remedial" antibody would not stop disease, however would counteract or postpone ailment in individuals who do get tainted, and may likewise lessen the danger of them transmitting the infection to others. Albeit a preventive antibody would be perfect, helpful immunizations would likewise be exceptionally gainful. The fundamental thought behind all HIV immunizations is to empower the human invulnerable framework to battle HIV.


  • BNT162b2/COMIRNATY Tozinameran (INN)-BioNTech Manufacturing GmbH
  • AZD1222 Vaxzevria --AstraZeneca, AB

Related Conference of Track 03: HIV Vaccines

August 22-23, 2022

4th World Congress on Vaccine and Immunology

Toronto, Canada
September 05-06, 2022

42nd Global Summit and Expo on Vaccines & Immunology

Paris, France
November 04-05, 2022

34th Annual Congress on Vaccine and Clinical Trials

Toronto, Canada
November 17-18, 2022

2nd Global Summit on Vaccines and Immunology

Berlin, Germany
February 20-21, 2023

International Conference on Vaccine Research

Madrid, Spain

Track 03: HIV Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in